1. Home
  2. LION vs NVAX Comparison

LION vs NVAX Comparison

Compare LION & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • NVAX
  • Stock Information
  • Founded
  • LION 1997
  • NVAX 1987
  • Country
  • LION United States
  • NVAX United States
  • Employees
  • LION N/A
  • NVAX N/A
  • Industry
  • LION Movies/Entertainment
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LION Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • LION Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LION 1.9B
  • NVAX 1.3B
  • IPO Year
  • LION N/A
  • NVAX 1995
  • Fundamental
  • Price
  • LION $7.17
  • NVAX $8.39
  • Analyst Decision
  • LION Buy
  • NVAX Buy
  • Analyst Count
  • LION 9
  • NVAX 7
  • Target Price
  • LION $8.88
  • NVAX $14.29
  • AVG Volume (30 Days)
  • LION 2.6M
  • NVAX 6.8M
  • Earning Date
  • LION 11-06-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • LION N/A
  • NVAX N/A
  • EPS Growth
  • LION N/A
  • NVAX N/A
  • EPS
  • LION N/A
  • NVAX 2.54
  • Revenue
  • LION $3,986,900,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • LION N/A
  • NVAX $61.69
  • Revenue Next Year
  • LION $16.90
  • NVAX N/A
  • P/E Ratio
  • LION N/A
  • NVAX $3.30
  • Revenue Growth
  • LION 10.89
  • NVAX 9.22
  • 52 Week Low
  • LION $5.55
  • NVAX $5.01
  • 52 Week High
  • LION $8.50
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • LION 60.87
  • NVAX 56.61
  • Support Level
  • LION $7.06
  • NVAX $7.83
  • Resistance Level
  • LION $7.69
  • NVAX $8.31
  • Average True Range (ATR)
  • LION 0.31
  • NVAX 0.38
  • MACD
  • LION 0.09
  • NVAX 0.05
  • Stochastic Oscillator
  • LION 66.98
  • NVAX 74.84

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: